Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-Current Assets (2020 - 2025)

Maxcyte (MXCT) has disclosed Non-Current Assets for 6 consecutive years, with $84.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 24.12% to $84.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $323.7 million through Dec 2025, up 8.41% year-over-year, with the annual reading at $84.1 million for FY2025, 24.12% up from the prior year.
  • Non-Current Assets for Q4 2025 was $84.1 million at Maxcyte, down from $88.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $88.8 million in Q3 2025, with the low at $8.2 million in Q3 2021.
  • Average Non-Current Assets over 5 years is $51.5 million, with a median of $52.4 million recorded in 2023.
  • The sharpest move saw Non-Current Assets skyrocketed 318.61% in 2022, then fell 13.18% in 2024.
  • Over 5 years, Non-Current Assets stood at $13.7 million in 2021, then skyrocketed by 151.23% to $34.4 million in 2022, then skyrocketed by 127.06% to $78.1 million in 2023, then fell by 13.18% to $67.8 million in 2024, then rose by 24.12% to $84.1 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $84.1 million, $88.8 million, and $76.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.